GAROFALO, MARIANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.696
AS - Asia 3.040
EU - Europa 1.564
AF - Africa 582
SA - Sud America 464
Continente sconosciuto - Info sul continente non disponibili 131
OC - Oceania 56
Totale 10.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.387
SG - Singapore 935
CN - Cina 511
IT - Italia 492
VN - Vietnam 426
HK - Hong Kong 274
BR - Brasile 271
BD - Bangladesh 180
FR - Francia 106
DE - Germania 104
FI - Finlandia 100
IN - India 79
PL - Polonia 70
GB - Regno Unito 59
NL - Olanda 58
AR - Argentina 47
RU - Federazione Russa 47
CA - Canada 46
IQ - Iraq 44
JP - Giappone 37
ID - Indonesia 36
BJ - Benin 34
ES - Italia 33
IE - Irlanda 30
IR - Iran 30
AT - Austria 29
PK - Pakistan 29
ZA - Sudafrica 29
TR - Turchia 28
UA - Ucraina 28
KR - Corea 27
JM - Giamaica 26
CO - Colombia 24
ET - Etiopia 24
JO - Giordania 24
PH - Filippine 24
SE - Svezia 24
EC - Ecuador 23
EG - Egitto 22
IL - Israele 22
CL - Cile 21
DZ - Algeria 21
GR - Grecia 21
NZ - Nuova Zelanda 21
SA - Arabia Saudita 21
CH - Svizzera 20
GE - Georgia 20
GN - Guinea 20
MA - Marocco 20
AE - Emirati Arabi Uniti 19
CR - Costa Rica 19
LB - Libano 19
LU - Lussemburgo 19
NO - Norvegia 19
NP - Nepal 19
PS - Palestinian Territory 19
RO - Romania 19
UZ - Uzbekistan 19
AO - Angola 18
CZ - Repubblica Ceca 18
GT - Guatemala 18
KE - Kenya 18
MX - Messico 18
MY - Malesia 18
PT - Portogallo 18
BO - Bolivia 17
ME - Montenegro 17
PY - Paraguay 17
ZM - Zambia 17
AL - Albania 16
AZ - Azerbaigian 16
BA - Bosnia-Erzegovina 16
CV - Capo Verde 16
DK - Danimarca 16
EE - Estonia 16
HN - Honduras 16
MK - Macedonia 16
MR - Mauritania 16
RS - Serbia 16
SI - Slovenia 16
UY - Uruguay 16
YT - Mayotte 16
ZW - Zimbabwe 16
BE - Belgio 15
CI - Costa d'Avorio 15
MD - Moldavia 15
ML - Mali 15
MW - Malawi 15
SN - Senegal 15
TW - Taiwan 15
XK - ???statistics.table.value.countryCode.XK??? 15
AF - Afghanistan, Repubblica islamica di 14
BB - Barbados 14
CU - Cuba 14
CY - Cipro 14
LC - Santa Lucia 14
LV - Lettonia 14
AD - Andorra 13
BZ - Belize 13
DJ - Gibuti 13
Totale 9.836
Salva come PNG Salva come JPEG
Città #
Ashburn 630
Singapore 509
Fairfield 508
San Jose 489
Seattle 230
Hong Kong 227
Woodbridge 213
Houston 180
Cambridge 177
Santa Clara 157
Ho Chi Minh City 136
Wilmington 136
Chandler 116
Los Angeles 107
Beijing 97
Hanoi 94
Ann Arbor 89
Boardman 87
Padova 87
Helsinki 69
Council Bluffs 67
Lauterbourg 58
Milan 55
San Diego 55
New York 54
Chicago 51
Medford 46
Princeton 45
Munich 42
Bytom 40
Cotonou 32
Hefei 32
Buffalo 31
Padua 30
São Paulo 30
Orem 29
Des Moines 28
Tokyo 26
Dong Ket 25
Dublin 25
Nuremberg 21
Amman 20
Conakry 20
Dallas 19
Warsaw 19
Addis Ababa 18
Haiphong 18
Baghdad 17
Guangzhou 17
Lappeenranta 17
Baku 16
London 16
Lusaka 16
Rome 16
Seoul 16
Tbilisi 16
Vienna 16
Athens 15
Bamako 15
Jinan 15
Kingston 15
Nairobi 15
Podgorica 15
Tashkent 15
Abidjan 14
Castries 14
Da Nang 14
Dakar 14
Frankfurt am Main 14
Havana 14
Luanda 14
Nouakchott 14
Rio de Janeiro 14
Amsterdam 13
Dushanbe 13
Montevideo 13
Panama City 13
Praia 13
San José 13
Stockholm 13
Andorra la Vella 12
Bridgetown 12
Guatemala City 12
Harare 12
Lilongwe 12
Ljubljana 12
Phoenix 12
Redondo Beach 12
Shenyang 12
Vientiane 12
Auckland 11
Bến Tre 11
Libreville 11
Luxembourg 11
Miami 11
Phnom Penh 11
Roxbury 11
Salt Lake City 11
Shanghai 11
Tallinn 11
Totale 5.989
Salva come PNG Salva come JPEG
Nome #
Physical PEGylation to Prevent Insulin Fibrillation 291
PEG-polyaminoacid based micelles for controlled release of doxorubicin: Rational design, safety and efficacy study 261
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 240
Dexamethasone loaded liposomes by thin‐film hydration and microfluidic procedures: Formulation challenges 236
Polymer coated oncolytic adenovirus to selectively target hepatocellular carcinoma cells 232
Extracellular vesicles powered cancer immunotherapy: Targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model 230
Thermosensitive "Smart" Surfaces for Biorecognition Based Cell Adhesion and Controlled Detachment 219
Oncolytic adenovirus loaded with L-carnosine as novel strategy to enhance the antitumor activity 214
Cancer vaccines: an update on recent achievements and prospects for cancer therapy 202
Development of nanovehicles for co-delivery of colistin and ArnT inhibitors 200
Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment 200
From Immunosuppression to Immunomodulation – Turning Cold Tumours into Hot 198
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma 196
Unlocking the potential of microfluidic assisted formulation of exenatide-loaded solid lipid nanoparticles 195
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma 191
Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model 188
Heterologous and cross-species tropism of cancer-derived extracellular vesicles 187
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma 182
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer 182
Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects 179
Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model 176
PCSK9 promotes arterial medial calcification 176
408. Oncolytic Vaccines in Combination with PD-L1 Blockade for the Treatment of Melanoma 175
661. Synergistic Anti-Tumor Efficacy of Immunogenic Adenovirus ONCOS-102 and Standard of Care Chemotherapy in Preclinical Mesothelioma Model 173
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks 171
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity 167
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation 167
Screening of chemical linkers for development of pullulan bioconjugates for intravitreal ocular applications 167
The evolution of adenoviral vectors through genetic and chemical surface modifications 164
The Anti-Proliferative Effect of L-Carnosine Correlates with a Decreased Expression of Hypoxia Inducible Factor 1 alpha in Human Colon Cancer Cells 160
Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies 157
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice. 156
220. Evaluation of the Efficacy of a New Oncolytic Vaccine Platform in Humanized Mice 153
Transplantation of autologous extracellular vesicles for cancer-specific targeting 152
Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs 151
Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review 149
71. Boosting the Immunogenicity of an Oncolytic Vaccinia Virus By Expression of DAI Can Enhance Anti-Tumor Immunity in Humanized Mice 147
Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform 146
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model 145
Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2 145
From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review 144
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity 143
The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers 141
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 140
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model 136
622. Oncolytic Adenoviruses Loaded With Active Drugs as a Novel Drug Delivery System for Cancer Therapy 134
Isoflavones in aglycone solution enhance ultraviolet B-induced DNA damage repair efficiency 132
How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs 131
Oncolytic Adenovirus-Based Immunotherapy for Malignant Mesothelioma: Preclinical Advances and Future Perspectives 129
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation 129
Oncolytic adenovirus loaded with L-carnosine as a drug delivery system for cancer therapy 128
L-Carnosine and Human Colon Cancer 123
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines 120
Erratum: The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells (PLoS ONE (2014) 9, 5 (e96755) DOI: 10.1371/journal.pone.0096755) 117
MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy 114
Localized treatment of glioblastoma: a review of clinical strategies and advances in drug delivery systems 107
Induction of an immune response by a nonreplicating adenoviruses-based formulation versus a commercial pseudo-SARS-CoV-2 vaccine 107
Application of array-CGH analysis in immune-virotherapy approach 103
In vitro immune evaluation of adenoviral vector-based platform for infectious diseases 98
Dynamic 3D microfluidic platform for exploring combined targeted therapy, chemotherapy, and virotherapy delivery in ovarian cancer 95
I Vaccini 89
L-Carnosine inhibits KRAS-mediated HCT116 proliferation, by affecting ROS production and Hypoxia inducible factor (HIF-1) expression 82
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 76
Oncologia 74
null 66
Development of an in vitro method to assess the immunogenicity of biologics in the prevention of infectious diseases 65
A 3D coculture model of hepatocellular carcinoma: addressing challenges with glycopolymers re-targeted oncolytic viruses 60
Doxorubicin liposomes cell penetration enhancement and its potential drawbacks for the tumor targeting efficiency 59
FYCO1 Peptide Analogs: Design and Characterization of Autophagy Inhibitors as Co-Adjuvants in Taxane Chemotherapy of Prostate Cancer 40
Redefining long-acting injectables: the emerging role of extracellular vesicles in sustained drug delivery 20
Breakable Organosilica Nanocapsules for the Intracellular Delivery of a Peptide With Promising Anti-Breast Cancer Activity 11
Totale 10.533
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.706
article - articoli 29.553
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 905
Totale 61.164
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022650 0 37 76 60 59 27 27 134 80 13 22 115
2022/2023335 73 1 4 23 70 46 1 38 46 3 15 15
2023/2024254 10 44 38 19 9 10 18 17 8 6 46 29
2024/20251.152 9 44 41 51 130 55 71 90 89 49 194 329
2025/20266.142 322 461 926 1.003 464 237 724 450 614 370 293 278
2026/2027406 319 87 0 0 0 0 0 0 0 0 0 0
Totale 10.533